Guidelines for Diagnosis and Management of Fungal Infections

Published in the Internal Medicine Journal: Vol 51 Supp.7: 1-233, 2021.

1. Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting, 2021.
   Internal Medicine Journal 51(S7):3-17.
2. Consensus guidelines for antifungal stewardship, surveillance and infection prevention, 2021
   Internal Medicine Journal 51(S7):18-36
3. Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021
   Internal Medicine Journal 51(S7):37-66
4. Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2021
   Internal Medicine Journal 51(S7):67-88
5. Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021
   Internal Medicine Journal 51(S7):89-117
6. Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting, 2021
   Internal Medicine Journal 51(S7):118-142
7. Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021
   Internal Medicine Journal 51(S7):143-176
8. Consensus guidelines for the diagnosis and management of invasive fungal disease due to moulds other than Aspergillus in the haematology/oncology setting, 2021
   Internal Medicine Journal 51(S7):177-219
9. Consensus guidelines for improving patients' understanding of invasive fungal disease and related risk prevention in the haematology/oncology setting, 2021
   Internal Medicine Journal 51(S7):220-233

Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM

Chang et al., 2024. Lancet Infectious Diseases, Online 9 Feb 2024.

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

Cornely et al., 2019. Lancet Infectious Diseases, 9(12):e405-e421

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. 

Donnelly et al., 2020. Clinical Infectious Diseases, 71(6):1367-1376.

Published in the Internal Medicine Journal. Vol 49 Issue 10:1229-1243, 2019

Diagnosis, management and prevention of Candida auris in hospitals: Position statement of the Australasian Society for Infectious Diseases

ESCMID-ECMM guideline: Diagnosis and management of invasive aspergillosis in neonates and children

Warris et al., 2019. Clinical Microbiology and Infection, 25(9):1096-1113

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

Patterson et al., 2016. Clinical Infectious Diseases, 63:e1-e60

Published in Clin Microbiol Infect 2014; 20 (Suppl. 3): 76–98

• ESCMID and ECMM joint clinical guidelines for the diagnosis andmanagement of rare invasive yeast infections.

Published in Clinical Microbiology and Infection 2011, 17, (supplement 5): 1-12

• Management of invasive candidiasis in adults

Website: www.idsociety.org - Published in Clinical Infectious Diseases

1. Guidelines introduction 2000 (CID 2000;30:652)
2. Antifungal agents 2000 (CID 2000;30:653–7)
3. Aspergillosis 2008 (CID 2008;46:327–360)
4. Blastomycosis 2008 (CID 2008;46:1801–1812)
5. Candidiasis 2009 (CID 2009;48:503–535)
6. Coccidioidomycosis 2008 (CID 2005;41:1217–1223)
7. Cryptococcosis 2010 (CID 2010;50:291-322)
8. Histoplasmosis 2007 (CID 2007;45:807–25)
9. Sporotrichosis 2007 (CID 2007; 5:1255–65)

ECIL is a common initiative of the following groups or organisations: Infectious Diseases Working Party of the European Blood and Marrow Transplantation Group (EBMT-IDWP), Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (EORTC-IDG), European Leukemia Net (ELN) (EU Grant No.: LSHC-CT-2004), and International Immunocompromised Host Society (ICHS).

• European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia. J Antimicrob Chemother 2018; 73: 3221–3230.
• ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother 2016; 71(9): 2386–2396.
• Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. Lancet Oncology 2014,15(8):e327-40.
• European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update (Bone Marrow Transplantation 2011, 46:709-718)
• Empirical antifungal therapy in neutropaenic cancer patients with persistent fever EJC Supplement S5:2007:32-42
• Primary antifungal prophylaxis in leukaemia patients EJC Supplement S5:2007:43-48
• Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients EJC Supplement S5:2007:49-59

An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients. Limper et al. 2011 Am J Respir Crit Care Med Vol 183. pp 96–128. Internet address: www.atsjournals.org

• Treatment of fungal infections in adult pulmonary and critical care patients

Prentice et al. 2010, British Society for Haematology

• Guidelines on the management of invasive fungal infection during therapy for haematological malignancy

Therapeutic Recommendations for the Treatment of Toenail Onychomycosis in the US, 2021.

Lipner et al., 2021. J Drugs Dermatol, 20(10):1076-1084

British Association of Dermatologists' Guidelines for the management of onychomycosis, 2014.

Ameen et al., 2014. Br J Dermatol, 171(5):937-58.

Guidelines for the management of tinea capitis. British Association of Dermatologists, 2014.

Fuller et al., 2014.  Br J Dermatol, 171(3):454-63.